Euclidean Capital LLC Pmv Pharmaceuticals, Inc. Call Options Transaction History
Euclidean Capital LLC
- $779 Million
- Q1 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PMVP
# of Institutions
106Shares Held
45.5MCall Options Held
2KPut Options Held
600-
Orbimed Advisors LLC San Diego, CA6.48MShares$10.5 Million0.25% of portfolio
-
Arrow Mark Colorado Holdings LLC Denver, CO3.2MShares$5.18 Million0.07% of portfolio
-
Black Rock Inc. New York, NY3.11MShares$5.04 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.45MShares$3.97 Million0.0% of portfolio
-
Alkeon Capital Management LLC New York, NY2.35MShares$3.8 Million0.01% of portfolio
About PMV Pharmaceuticals, Inc.
- Ticker PMVP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 45,622,600
- Market Cap $73.9M
- Description
- PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...